MINAR2
gene geneOn this page
Summary
MINAR2 (membrane integral NOTCH2 associated receptor 2, HGNC:33914) is a protein-coding gene on chromosome 5q23.3, encoding Major intrinsically disordered NOTCH2-binding receptor 1-like (P59773). Binds cholesterol and may regulate the distribution and homeostasis of cholesterol in hair cells.
Enables cholesterol binding activity. Involved in angiogenesis. Located in endoplasmic reticulum. Implicated in autosomal recessive nonsyndromic deafness.
Source: NCBI Gene 100127206 — RefSeq curated summary.
At a glance
- Gene–disease (curated): hearing loss, autosomal recessive 120 (Strong, GenCC)
- GWAS associations: 5
- Clinical variants (ClinVar): 9 total — 3 pathogenic
- Phenotypes (HPO): 3
- MANE Select transcript:
NM_001257308
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33914 |
| Approved symbol | MINAR2 |
| Name | membrane integral NOTCH2 associated receptor 2 |
| Location | 5q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000186367 |
| Ensembl biotype | protein_coding |
| OMIM | 620215 |
| Entrez | 100127206 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000564719
RefSeq mRNA: 1 — MANE Select: NM_001257308
NM_001257308
CCDS: CCDS58966
Canonical transcript exons
ENST00000564719 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002024810 | 129760378 | 129760605 |
| ENSE00002048030 | 129748094 | 129748355 |
| ENSE00002585911 | 129764884 | 129766732 |
Expression profiles
Bgee: expression breadth broad, 29 present calls, max score 71.38.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0212 / max 12.1400, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 58382 | 0.0212 | 4 |
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.38 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 52.16 | gold quality |
| sural nerve | UBERON:0015488 | 51.58 | gold quality |
| muscle tissue | UBERON:0002385 | 50.86 | gold quality |
| monocyte | CL:0000576 | 50.21 | gold quality |
| leukocyte | CL:0000738 | 49.27 | gold quality |
| duodenum | UBERON:0002114 | 46.35 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 45.13 | gold quality |
| endometrium | UBERON:0001295 | 43.11 | silver quality |
| adrenal tissue | UBERON:0018303 | 41.71 | silver quality |
| body of uterus | UBERON:0009853 | 41.68 | gold quality |
| ectocervix | UBERON:0012249 | 41.24 | gold quality |
| placenta | UBERON:0001987 | 40.75 | gold quality |
| ganglionic eminence | UBERON:0004023 | 40.69 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 40.58 | silver quality |
| lower esophagus | UBERON:0013473 | 40.53 | silver quality |
| bone marrow cell | CL:0002092 | 40.32 | gold quality |
| hypothalamus | UBERON:0001898 | 40.18 | gold quality |
| cortical plate | UBERON:0005343 | 40.07 | gold quality |
| ventricular zone | UBERON:0003053 | 40.03 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 39.28 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 38.75 | gold quality |
| blood | UBERON:0000178 | 38.63 | gold quality |
| bone marrow | UBERON:0002371 | 38.59 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 38.45 | gold quality |
| left uterine tube | UBERON:0001303 | 38.42 | gold quality |
| liver | UBERON:0002107 | 37.45 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.97 | silver quality |
| granulocyte | CL:0000094 | 36.91 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.77 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Mutations in MINAR2 encoding membrane integral NOTCH2-associated receptor 2 cause deafness in humans and mice. (PMID:35727972)
- Inactivation of Minar2 in mice hyperactivates mTOR signaling and results in obesity. (PMID:37245847)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | minar2 | ENSDARG00000078922 |
| mus_musculus | Minar2 | ENSMUSG00000050875 |
| rattus_norvegicus | Minar2 | ENSRNOG00000022429 |
Paralogs (1): MINAR1 (ENSG00000169330)
Protein
Protein identifiers
Major intrinsically disordered NOTCH2-binding receptor 1-like — P59773 (reviewed: P59773)
Alternative names: Major intrinsically disordered NOTCH2-associated receptor 2, Membrane integral NOTCH2-associated receptor 2
All UniProt accessions (1): P59773
UniProt curated annotations — full annotation on UniProt →
Function. Binds cholesterol and may regulate the distribution and homeostasis of cholesterol in hair cells. May play a role in angiogenesis.
Subunit / interactions. Interacts with NOTCH2.
Subcellular location. Lysosome membrane. Endoplasmic reticulum membrane.
Tissue specificity. Highly expressed in the auditory hair cells.
Disease relevance. Deafness, autosomal recessive, 120 (DFNB120) [MIM:620238] A form of non-syndromic deafness characterized by congenital or prelingual onset of severe to profound sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the MINAR family.
RefSeq proteins (1): NP_001244237* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009626 | MINAR1-like_C | Domain |
| IPR039706 | MINAR1-like | Family |
Pfam: PF06789
UniProt features (8 total): glycosylation site 2, mutagenesis site 2, chain 1, transmembrane region 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59773-F1 | 62.70 | 0.10 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 79
Glycosylation sites (2): 109, 125
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 112 | compromises cholesterol recruitment to the perinuclear region; when associated with a-117. |
| 117 | compromises cholesterol recruitment to the perinuclear region; when associated with a-112. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 69 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_BEHAVIOR, GOBP_STEROL_HOMEOSTASIS, GOCC_VACUOLAR_MEMBRANE, GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS, GOBP_NEUROGENESIS, GOBP_LIPID_HOMEOSTASIS, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_EAR_DEVELOPMENT, GOBP_BLOOD_VESSEL_MORPHOGENESIS, GOBP_EPIDERMIS_DEVELOPMENT, GOBP_NEURON_APOPTOTIC_PROCESS, GOBP_MECHANORECEPTOR_DIFFERENTIATION, GOBP_HAIR_CELL_DIFFERENTIATION, GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS
GO Biological Process (13): angiogenesis (GO:0001525), sensory perception of sound (GO:0007605), gene expression (GO:0010467), exploration behavior (GO:0035640), inner ear auditory receptor cell differentiation (GO:0042491), cholesterol homeostasis (GO:0042632), homeostasis of number of cells within a tissue (GO:0048873), neuron apoptotic process (GO:0051402), inner ear receptor cell stereocilium organization (GO:0060122), walking behavior (GO:0090659), apoptotic process (GO:0006915), locomotory behavior (GO:0007626), inner ear receptor cell differentiation (GO:0060113)
GO Molecular Function (2): cholesterol binding (GO:0015485), protein binding (GO:0005515)
GO Cellular Component (6): lysosomal membrane (GO:0005765), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), stereocilium (GO:0032420), lysosome (GO:0005764), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| behavior | 2 |
| blood vessel morphogenesis | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| sensory perception of mechanical stimulus | 1 |
| macromolecule biosynthetic process | 1 |
| hair cell differentiation | 1 |
| inner ear receptor cell differentiation | 1 |
| sterol homeostasis | 1 |
| tissue homeostasis | 1 |
| homeostasis of number of cells | 1 |
| apoptotic process | 1 |
| neuron projection development | 1 |
| inner ear receptor cell development | 1 |
| locomotory behavior | 1 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| mechanoreceptor differentiation | 1 |
| inner ear development | 1 |
| sterol binding | 1 |
| alcohol binding | 1 |
| binding | 1 |
| lysosome | 1 |
| lytic vacuole membrane | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| stereocilium bundle | 1 |
| neuron projection | 1 |
| actin-based cell projection | 1 |
| lytic vacuole | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
76 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MINAR2 | SPMIP10 | Q6ZNM6 | 607 |
| MINAR2 | C5orf63 | A6NC05 | 542 |
| MINAR2 | PRRC1 | Q96M27 | 507 |
| MINAR2 | ISOC1 | Q96CN7 | 479 |
| MINAR2 | GRAMD2B | Q96HH9 | 479 |
| MINAR2 | OCM2 | P0CE71 | 435 |
| MINAR2 | MARCHF3 | Q86UD3 | 432 |
| MINAR2 | ZNF608 | Q9ULD9 | 418 |
| MINAR2 | CTXN3 | Q4LDR2 | 417 |
| MINAR2 | ADAMTS19 | Q8TE59 | 380 |
| MINAR2 | PHAX | Q9H814 | 371 |
| MINAR2 | RHOBTB3 | O94955 | 352 |
| MINAR2 | SLC27A6 | Q9Y2P4 | 322 |
| MINAR2 | CEP68 | Q76N32 | 305 |
| MINAR2 | ADGRV1 | Q8WXG9 | 276 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2VE00, A5PK14, F1QEA1, O75324, P0DKX4, P20826, P21581, P21583, P58550, P59773, P61807, P61808, P79169, P79368, Q06220, Q09108, Q10589, Q15053, Q17Q87, Q28132, Q28C41, Q28GJ0, Q29030, Q2T9X8, Q3UQS2, Q5PQQ9, Q5RBY6, Q5RKG1, Q5U3Z6, Q640L3, Q6AY06, Q6DF94, Q6IQY5, Q6NRX3, Q811A2, Q86YF9, Q8BIS8, Q8BMD2, Q8C804, Q8N0Z3
Diamond homologs: A0A140LFM6, D3ZJ47, F1QEA1, P59773, Q8C4X7, Q8K3V7, Q9UPX6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2443700 | NM_001257308.2(MINAR2):c.144G>A (p.Trp48Ter) | Pathogenic |
| 2443701 | NM_001257308.2(MINAR2):c.412_419del (p.Arg138fs) | Pathogenic |
| 2443702 | NM_001257308.2(MINAR2):c.393G>T (p.Lys131Asn) | Pathogenic |
SpliceAI
498 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:129748356:GTA:G | donor_loss | 1.0000 |
| 5:129748357:T:A | donor_loss | 1.0000 |
| 5:129758756:T:G | donor_gain | 1.0000 |
| 5:129758756:T:TG | donor_gain | 1.0000 |
| 5:129760644:GGAGA:G | donor_gain | 0.9900 |
| 5:129760376:A:AG | acceptor_gain | 0.9800 |
| 5:129760376:AGAG:A | acceptor_gain | 0.9800 |
| 5:129760377:G:GG | acceptor_gain | 0.9800 |
| 5:129760377:GA:G | acceptor_gain | 0.9800 |
| 5:129760377:GAGG:G | acceptor_gain | 0.9800 |
| 5:129758760:G:GG | donor_gain | 0.9700 |
| 5:129760558:GAA:G | donor_gain | 0.9700 |
| 5:129758759:A:AG | donor_gain | 0.9600 |
| 5:129760376:AGAGG:A | acceptor_gain | 0.9600 |
| 5:129760377:GAGGG:G | acceptor_gain | 0.9600 |
| 5:129764883:GGAAA:G | acceptor_gain | 0.9600 |
| 5:129764878:TTTTA:T | acceptor_loss | 0.9500 |
| 5:129764879:TTTA:T | acceptor_loss | 0.9500 |
| 5:129764880:TTAG:T | acceptor_loss | 0.9500 |
| 5:129764881:TAGGA:T | acceptor_loss | 0.9500 |
| 5:129764882:A:AG | acceptor_gain | 0.9500 |
| 5:129764883:G:GG | acceptor_gain | 0.9500 |
| 5:129748356:G:GG | donor_gain | 0.9400 |
| 5:129748990:T:TG | donor_gain | 0.9400 |
| 5:129758755:A:AG | donor_gain | 0.9300 |
| 5:129758772:C:G | donor_gain | 0.9300 |
| 5:129764868:T:TA | acceptor_loss | 0.9200 |
| 5:129764883:GGA:G | acceptor_gain | 0.9200 |
| 5:129758755:A:G | donor_gain | 0.9100 |
| 5:129760372:TCTTA:T | acceptor_loss | 0.9100 |
AlphaMissense
1251 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:129764905:T:C | F139L | 0.986 |
| 5:129764907:T:A | F139L | 0.986 |
| 5:129764907:T:G | F139L | 0.986 |
| 5:129764935:T:C | F149L | 0.982 |
| 5:129764937:T:A | F149L | 0.982 |
| 5:129764937:T:G | F149L | 0.982 |
| 5:129764908:T:A | W140R | 0.981 |
| 5:129764908:T:C | W140R | 0.981 |
| 5:129764910:G:C | W140C | 0.977 |
| 5:129764910:G:T | W140C | 0.977 |
| 5:129760548:G:C | W112C | 0.952 |
| 5:129760548:G:T | W112C | 0.952 |
| 5:129764906:T:C | F139S | 0.947 |
| 5:129748207:T:C | L6S | 0.946 |
| 5:129760546:T:A | W112R | 0.944 |
| 5:129760546:T:C | W112R | 0.944 |
| 5:129764936:T:C | F149S | 0.943 |
| 5:129764908:T:G | W140G | 0.940 |
| 5:129764948:T:C | L153S | 0.936 |
| 5:129748220:C:A | N10K | 0.934 |
| 5:129748220:C:G | N10K | 0.934 |
| 5:129748334:G:C | W48C | 0.931 |
| 5:129748334:G:T | W48C | 0.931 |
| 5:129764909:G:C | W140S | 0.930 |
| 5:129748234:T:C | F15S | 0.929 |
| 5:129748243:T:C | L18P | 0.929 |
| 5:129748233:T:C | F15L | 0.928 |
| 5:129748235:C:A | F15L | 0.928 |
| 5:129748235:C:G | F15L | 0.928 |
| 5:129748214:T:A | N8K | 0.920 |
dbSNP variants (sampled 300 via entrez): RS1000071230 (5:129750580 A>G), RS1000080732 (5:129750274 G>A,C), RS1000096388 (5:129755767 T>C), RS1000117237 (5:129757347 A>C), RS1000189553 (5:129755746 T>C), RS1000633519 (5:129747617 C>A,T), RS1000698574 (5:129753968 T>C), RS1000713883 (5:129761416 G>A,T), RS1001166813 (5:129759698 C>A), RS1001586686 (5:129752937 A>T), RS1001601970 (5:129765515 T>G), RS1001719503 (5:129760011 A>C,G,T), RS1001815655 (5:129752402 A>T), RS1002099555 (5:129752678 A>G), RS1002169601 (5:129758107 A>G)
Disease associations
OMIM: gene MIM:620215 | disease phenotypes: MIM:620238
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| hearing loss, autosomal recessive 120 | Strong | Autosomal recessive |
Mondo (1): hearing loss, autosomal recessive 120 (MONDO:0859374)
Orphanet (0):
HPO phenotypes
3 total (3 of 3 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0003577 | Congenital onset |
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009724_48 | Vertical cup-disc ratio (multi-trait analysis) | 8.000000e-10 |
| GCST010701_92 | Cortical surface area (MOSTest) | 9.000000e-14 |
| GCST010702_112 | Subcortical volume (MOSTest) | 1.000000e-09 |
| GCST010703_249 | Brain morphology (MOSTest) | 2.000000e-14 |
| GCST012227_187 | Hip circumference adjusted for BMI | 5.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006939 | cup-to-disc ratio measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Diethylhexyl Phthalate | decreases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: hearing loss, autosomal recessive 120
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hearing loss, autosomal recessive 120